Skip to main content
. 2014 Dec 9;1(1):1–20. doi: 10.1007/s40744-014-0005-4

Fig. 6.

Fig. 6

American College of Rheumatology 20 (ACR20) response over 52 weeks in a patients initially randomized to apremilast 20 mg twice daily (BID) and b patients initially randomized to apremilast 30 mg BID (data as observed). PALACE Psoriatic Arthritis Long-term Assessment of Clinical Efficacy. Reproduced with permission from Blanco et al. [33]